American Cannabis Company Inc (AMMJ)

[Drugdoctor]

NT- 10Q filed - 5 day extension.....

PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR , N-CSR or the transition report or portion thereof, could not be filed within the prescribed period.

The registrant is in the process of preparing and reviewing the financial information of the Company on a consolidated basis. The process of compiling and disseminating the information required to be included in the Form 10-QSB for the relevant fiscal quarter, as well as the completion of the required review of the Company's financial information on a consolidated basis, could not be completed without incurring undue hardship and expense. The registrant undertakes the responsibility to file such quarterly report no later than five days after its original date.



PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification: James R. Arabia, President: [phone].

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). |X| Yes |_| No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? |X| Yes |_| No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The Company anticipates that it will report a net loss of approximately $472,00 for the period ending September 30, 2007 versus a net loss of $431,216 for the period ending September 30, 2006. The increase in net loss is primarily due to an increase of interest expense and increased costs and expenses associated with the expansion of the Company's business.

Naturewell, Incorporated has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.


Date: November 14, 2007
Naturewell, Incorporated


By: /s/ James R. Arabia
--------------------------------------
James R. Arabia
President and Chief Executive Officer